ZA989982B - Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them - Google Patents

Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them

Info

Publication number
ZA989982B
ZA989982B ZA989982A ZA989982A ZA989982B ZA 989982 B ZA989982 B ZA 989982B ZA 989982 A ZA989982 A ZA 989982A ZA 989982 A ZA989982 A ZA 989982A ZA 989982 B ZA989982 B ZA 989982B
Authority
ZA
South Africa
Prior art keywords
sulfonamide
medicament
preparation
pharmaceutical preparations
benzopyran derivatives
Prior art date
Application number
ZA989982A
Other languages
English (en)
Inventor
Joachim Brendel
Uwe Gerlach
Hans Jochen Lang
Klaus Weidmann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ZA989982B publication Critical patent/ZA989982B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA989982A 1997-11-03 1998-11-02 Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them ZA989982B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19748469A DE19748469A1 (de) 1997-11-03 1997-11-03 Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ZA989982B true ZA989982B (en) 1999-06-24

Family

ID=7847428

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA989982A ZA989982B (en) 1997-11-03 1998-11-02 Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them

Country Status (29)

Country Link
US (1) US6008245A (es)
EP (1) EP0913396B1 (es)
JP (1) JP4430749B2 (es)
KR (1) KR19990044961A (es)
CN (1) CN1218050A (es)
AR (1) AR015997A1 (es)
AT (1) ATE250051T1 (es)
AU (1) AU740814B2 (es)
BR (1) BR9805088A (es)
CA (1) CA2252733A1 (es)
CZ (1) CZ293913B6 (es)
DE (2) DE19748469A1 (es)
DK (1) DK0913396T3 (es)
ES (1) ES2203867T3 (es)
HR (1) HRP980576B1 (es)
HU (1) HUP9802518A3 (es)
ID (1) ID21209A (es)
IL (1) IL126855A (es)
MY (1) MY118262A (es)
NO (1) NO985023L (es)
NZ (1) NZ332575A (es)
PL (1) PL329437A1 (es)
PT (1) PT913396E (es)
RU (1) RU2225403C2 (es)
SI (1) SI0913396T1 (es)
SK (1) SK284859B6 (es)
TR (1) TR199802200A2 (es)
TW (1) TW593307B (es)
ZA (1) ZA989982B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408940A (en) * 1992-06-25 1995-04-25 Winchell; Paul W. Adjustable height work surface wtih rack and pinion arrangements
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
KR100545780B1 (ko) * 2003-05-28 2006-01-24 동부한농화학 주식회사 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물
KR100512486B1 (ko) * 2003-05-28 2005-09-06 동부한농화학 주식회사 싸이옥소벤즈옥사졸 유도체로 치환된 벤조피란 유도체또는 약학적으로 허용되는 염, 이의 제조방법 및 이를포함하는 약학적 조성물
CN101160301B (zh) * 2005-04-12 2012-03-28 索尔瓦药物有限公司 氨基烷基-酰胺基甲基-取代的2-(4-磺酰基氨基)-3-羟基-3,4-二氢-2h-色烯-6-基衍生物以及它们作为钾通道阻断剂的用途
EP2595623B1 (en) 2010-07-19 2018-02-28 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of delta tocopherol for the treatment of lysosomal storage disorders
EP2920161B1 (en) 2012-11-16 2019-08-14 THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
US9573921B2 (en) * 2013-09-30 2017-02-21 Polfarmex S.A. Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H1-receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
DE19748469A1 (de) 1999-05-06
BR9805088A (pt) 2000-03-21
ATE250051T1 (de) 2003-10-15
SK284859B6 (sk) 2006-01-05
EP0913396A3 (de) 2001-03-21
HRP980576B1 (en) 2002-10-31
IL126855A0 (en) 1999-09-22
SK149498A3 (en) 1999-05-07
SI0913396T1 (en) 2004-02-29
TR199802200A3 (tr) 1999-05-21
JPH11222485A (ja) 1999-08-17
KR19990044961A (ko) 1999-06-25
PT913396E (pt) 2004-02-27
CN1218050A (zh) 1999-06-02
NO985023D0 (no) 1998-10-28
MY118262A (en) 2004-09-30
AR015997A1 (es) 2001-05-30
ES2203867T3 (es) 2004-04-16
PL329437A1 (en) 1999-05-10
DK0913396T3 (da) 2003-12-22
AU740814B2 (en) 2001-11-15
HU9802518D0 (en) 1998-12-28
CA2252733A1 (en) 1999-05-03
AU9043798A (en) 1999-05-20
EP0913396A2 (de) 1999-05-06
CZ293913B6 (cs) 2004-08-18
ID21209A (id) 1999-05-06
DE59809628D1 (de) 2003-10-23
RU2225403C2 (ru) 2004-03-10
HUP9802518A3 (en) 2001-10-29
HUP9802518A2 (hu) 2000-06-28
US6008245A (en) 1999-12-28
TW593307B (en) 2004-06-21
EP0913396B1 (de) 2003-09-17
HRP980576A2 (en) 1999-06-30
CZ350898A3 (cs) 1999-05-12
NO985023L (no) 1999-05-04
NZ332575A (en) 2000-03-27
IL126855A (en) 2003-03-12
TR199802200A2 (xx) 1999-05-21
JP4430749B2 (ja) 2010-03-10

Similar Documents

Publication Publication Date Title
HUP0002517A3 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments
IL120827A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic and medicament comprising them
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
NZ230868A (en) Dihydroartemisinin derivatives, preparation and pharmaceutical compositions thereof
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
ZA988788B (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
AR013264A1 (es) Derivados de 4-oxo-3,5-dihidro-4h-piridazino[4,5-b]indol-1-acetamida, medicamento y composicinn farmaceutica
ZA989982B (en) Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them
IL123360A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic aid and medicaments comprising them
IL89968A (en) 4-oxo quinazoline derivatives, processes for their preparation and pharmaceutical compositions comprising them
AU8604598A (en) Pharmaceutical formulation for camptothecin analogues in gelatin capsule
ZA988790B (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic and pharmaceutical preparations comprising them
IL126955A0 (en) Sulfonamide-substituted fused 5-membered ring compounds their use as a medicament and pharmaceutical preparations comprising them
ZA981562B (en) Sulfonamide-substituted fused 7-membered ring compounds their use as a medicament and pharmaceutical preparations comprising them
IL125642A0 (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL127690A0 (en) Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them
HK1047037B (zh) 含聚殼糖的蘭諾索爾(毫微溶膠)藥物製劑及其製備
IL146276A0 (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
IL123229A0 (en) Sulfonamide-substituted compounds process for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
ZA9711245B (en) Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them.
ZA986967B (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicament comprising them
ZA986340B (en) Medicaments comprising polyhydroxyalkylpyrazine derivatives novel polyhydrosyalkylpyrazine derivatives and their preparation